Followers | 15 |
Posts | 1821 |
Boards Moderated | 0 |
Alias Born | 04/16/2024 |
Friday, June 28, 2024 12:22:59 PM
not unreasonable to accuse management of theft
Recent KPTI News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/16/2024 09:00:03 PM
- Karyopharm Announces the Appointment of Brendan Strong as Senior Vice President of Investor Relations and Corporate Communications • PR Newswire (US) • 12/09/2024 01:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/05/2024 09:35:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2024 09:15:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/03/2024 12:09:59 PM
- Karyopharm Therapeutics Provides Endometrial Cancer Program Update • PR Newswire (US) • 12/03/2024 12:00:00 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 12/02/2024 12:00:00 PM
- Karyopharm to Participate at the Piper Sandler 36th Annual Healthcare Conference • PR Newswire (US) • 11/25/2024 12:00:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/22/2024 09:01:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2024 09:11:30 PM
- Karyopharm Therapeutics Announces the Appointment of Chief Accounting Officer • PR Newswire (US) • 11/20/2024 09:05:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 11/14/2024 09:22:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2024 09:05:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/06/2024 09:06:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/05/2024 01:02:08 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/05/2024 12:47:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2024 12:41:59 PM
- Karyopharm Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress • PR Newswire (US) • 11/05/2024 12:30:00 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 11/01/2024 08:05:00 PM
- Karyopharm to Report Third Quarter 2024 Financial Results on November 5, 2024 • PR Newswire (US) • 10/31/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 11:41:58 AM
- Karyopharm Announces Favorable Change in Co-Primary Endpoint for Pivotal Phase 3 SENTRY Trial in Myelofibrosis • PR Newswire (US) • 10/31/2024 11:30:00 AM
- Karyopharm to Host Investor Event with Leading Myelofibrosis KOLs and Provide a Favorable Study Design Update on October 31, 2024 • PR Newswire (US) • 10/30/2024 08:30:00 PM
- Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 10/01/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 08:10:30 PM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM